From the Department of Renal Medicine, St. George’s Hospital (SVB, AT), the Renal and Metabolic Division, the George Institute for Global Health (SVB, AT, VP) and the St. Vincent Clinical School (ROD, GRDJ), University of New South Wales Medicine, Departments of Clinical Pharmacology and Toxicology (ROD) and Chemical Pathology, SydPath (GRDJ), St. Vincent Hospital, Center for Kidney Transplantation and Research, Westmead Institute for Medical Research, University of Sydney (DCH, GKR). ), the Department of Renal Medicine, Westmead Hospital, Western Sydney Local Health District (DCH, GKR), and the Department of Nephrology, Royal North Shore Hospital (VP), Sydney, Australasian Kidney Trials Network, University of Queensland (SVB , EMP, NB, CMH, DR, LR, DWJ), the Department of Nephrology, Princess Alexandra Hospital, (BD, CMH, DWJ) and the Translational Research Institute (DWJ), Brisbane, QLD, The College of Medicine of the University of Western Australia, Perth (NB), the Department of Nephrology, Monash University at Monash Medical Center, Melbourne, VIC (FGB, JK), Menzies School of Health Research, Charles Darwin University, Darwin, NT (AC), University of Adelaide and Central Northern Adelaide Renal and Transplantation Services, Adelaide, SA (RF), and the School of Medicine of the National University of Australia and the Department of Nephrology, Canberra Hospital, Canberra, ACT (GW), all in Australia; the Center for Health Economics Research, Nuffield Department of Population Health, University of Oxford, Oxford, UK (PC); and the University of Auckland Department of Medicine (ND, JRZ), and the Kidney Service, Waitemata District Board of Health (JRZ), Auckland, Department of Medicine, University of Otago Christchurch, Christchurch (SCP) and Dunedin School of Medicine, University of Otago, Dunedin (RJW), all in New Zealand.
Address reprint requests to Dr. Badve at the Kidney and Metabolic Division, The George Institute for Global Health, Level 5, 1 King St., Newtown, NSW 2042, Australia, or at [email protected].
